PARNAXLABPharmaceuticals
Parnax Lab Ltd — Cash Flow Statement
₹128.55
-2.85%
Parnax Lab Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 13.72 Cr | -16.62 Cr | 9.63 Cr | -7.71 Cr | — |
| Repayment Of Debt | -10.42 Cr | — | -14.57 Cr | — | -3.19 Cr |
| Issuance Of Capital Stock | 0.00 | 0.00 | 5.45 Cr | 7.52 Cr | — |
| Capital Expenditure | -18.58 Cr | -32.49 Cr | -11.28 Cr | -16.26 Cr | — |
| End Cash Position | 0.55 Cr | 0.46 Cr | 1.28 Cr | 4.36 Cr | — |
| Beginning Cash Position | 0.46 Cr | 1.28 Cr | 4.36 Cr | 0.18 Cr | — |
| Changes In Cash | 0.09 Cr | -0.82 Cr | -3.08 Cr | 4.18 Cr | — |
| Financing Cash Flow | -15.82 Cr | 14.82 Cr | -14.07 Cr | 12.13 Cr | — |
| Interest Paid Cff | -5.39 Cr | -5.35 Cr | -4.95 Cr | -5.23 Cr | — |
| Net Common Stock Issuance | 0.00 | 0.00 | 5.45 Cr | 7.52 Cr | — |
| Common Stock Issuance | 0.00 | 0.00 | 5.45 Cr | 7.52 Cr | — |
| Net Issuance Payments Of Debt | -10.42 Cr | 20.16 Cr | -14.57 Cr | 9.85 Cr | — |
| Net Short Term Debt Issuance | -7.36 Cr | 11.13 Cr | -9.18 Cr | 6.41 Cr | — |
| Short Term Debt Payments | -7.36 Cr | — | -9.18 Cr | — | — |
| Net Long Term Debt Issuance | -3.07 Cr | 9.03 Cr | -5.39 Cr | 3.43 Cr | — |
| Long Term Debt Payments | -3.07 Cr | — | -5.39 Cr | — | -3.19 Cr |
| Investing Cash Flow | -16.39 Cr | -31.52 Cr | -9.92 Cr | -16.50 Cr | — |
| Net Other Investing Changes | 1000.00 | -0.08 Cr | -1000.00 | -10.00 | — |
| Interest Received Cfi | 0.18 Cr | 0.42 Cr | 0.11 Cr | 0.09 Cr | — |
| Net Investment Purchase And Sale | -0.71 Cr | 0.08 Cr | -0.02 Cr | -0.33 Cr | — |
| Purchase Of Investment | -0.71 Cr | 0.00 | -0.08 Cr | -0.33 Cr | — |
| Net PPE Purchase And Sale | -7.04 Cr | -13.65 Cr | -10.02 Cr | -17.82 Cr | — |
| Sale Of PPE | 2.71 Cr | 0.48 Cr | 1.26 Cr | 50000.00 | — |
| Purchase Of PPE | -9.75 Cr | -14.14 Cr | -11.28 Cr | -17.83 Cr | — |
| Capital Expenditure Reported | -8.83 Cr | -18.36 Cr | 1.01 Cr | 1.57 Cr | — |
| Operating Cash Flow | 32.30 Cr | 15.88 Cr | 20.91 Cr | 8.55 Cr | — |
| Taxes Refund Paid | -2.74 Cr | -2.64 Cr | -2.86 Cr | -0.24 Cr | — |
| Change In Working Capital | 6.53 Cr | -5.40 Cr | -0.09 Cr | -14.53 Cr | — |
| Change In Other Current Liabilities | 0.72 Cr | 0.25 Cr | -1.40 Cr | 3.53 Cr | — |
| Change In Other Current Assets | 2.19 Cr | -1.66 Cr | 0.21 Cr | -3.35 Cr | — |
| Change In Payable | -2.33 Cr | 8.92 Cr | -7.95 Cr | 15.61 Cr | — |
| Change In Inventory | 4.16 Cr | -8.24 Cr | -1.76 Cr | -9.14 Cr | — |
| Change In Receivables | 1.79 Cr | -4.67 Cr | 10.81 Cr | -21.18 Cr | — |
| Other Non Cash Items | 5.21 Cr | 4.93 Cr | 5.07 Cr | 5.19 Cr | — |
| Depreciation And Amortization | 7.38 Cr | 6.96 Cr | 6.53 Cr | 5.87 Cr | — |
| Depreciation | 7.38 Cr | 6.96 Cr | 6.47 Cr | 5.80 Cr | — |
| Gain Loss On Sale Of PPE | 0.25 Cr | -0.03 Cr | -0.01 Cr | -31000.00 | — |
| Net Income From Continuing Operations | 15.67 Cr | 12.05 Cr | 12.28 Cr | 12.26 Cr | — |
| Issuance Of Debt | — | 20.16 Cr | — | 9.85 Cr | 8.32 Cr |
| Net Other Financing Charges | — | 1000.00 | 1000.00 | — | — |
| Short Term Debt Issuance | — | 11.13 Cr | — | 6.41 Cr | 8.32 Cr |
| Long Term Debt Issuance | — | 9.03 Cr | — | 3.43 Cr | 3.63 Cr |
| Sale Of Investment | — | 0.08 Cr | 0.06 Cr | 0.00 | — |
| Amortization Cash Flow | — | 0.11 Cr | 0.06 Cr | 0.07 Cr | 0.06 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | 10.00 | -10.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Parnax Lab Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.